Role of SUCLA2 in anoikis resistance and tumor metastasis
SUCLA2 在失巢凋亡抵抗和肿瘤转移中的作用
基本信息
- 批准号:10212278
- 负责人:
- 金额:$ 1.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-26 至 2021-08-29
- 项目状态:已结题
- 来源:
- 关键词:A549AnoikisAntioxidantsApoptoticBioenergeticsBiogenesisBioinformaticsBiological AssayBlood VesselsCancer PatientCancer PrognosisCancer cell lineCardiovascular systemCell DeathCell SurvivalCellsCessation of lifeClinicalComplexCustomDataDatabasesDisseminated Malignant NeoplasmDistantElectron TransportEnzymesExhibitsExtracellular MatrixFutureGenesGeneticGlutamate DehydrogenaseGoalsHomeostasisHumanImageImmunohistochemistryIn VitroInjectionsLaboratoriesLipidsMalignant NeoplasmsMalignant neoplasm of lungMediatingMetabolicMetabolic PathwayMetabolismMetastatic Neoplasm to the LungMitochondriaMolecularMonitorMusNeoplasm Circulating CellsNeoplasm MetastasisNonmetastaticNutrientOrganOxidation-ReductionOxidative PhosphorylationOxygen ConsumptionPathway interactionsPatientsPlayPrimary NeoplasmProcessProductionProteinsRNARNA interference screenReactive Oxygen SpeciesReportingResearchResistanceRoleSTK11 geneSignal TransductionStainsSuccinate-CoA LigasesSuccinatesSupplementationTailTestingTissuesUric AcidVeinsWarburg EffectXenograft procedureaerobic glycolysisbiomarker identificationcancer cellcancer therapyexperimental studyimprovedin vivoinsightknock-downlung cancer celllymphatic vesselmRNA Expressionmetabolomicsmutantneoplastic cellnew therapeutic targetnoveloverexpressionpreferenceprogramsrefractory cancerresponsesmall hairpin RNAtargeted biomarkertherapeutic targettumortumor growthvector
项目摘要
PROJECT SUMMARY
Metastatic cancer is difficult to treat and often incurable. Characterizing pro-metastatic cellular pathways is
therefore crucial for identifying new therapeutic targets and biomarkers for metastasis to improve clinical
prognosis of cancer patients. Dysregulated cellular metabolism is a well-established hallmark of cancer, but a
growing body of research highlights metabolic differences between primary and metastatic cancer cells. While
highly proliferative primary tumor cells often exhibit the Warburg effect, marked by a preference for aerobic
glycolysis to generate ATP, genes for mitochondrial biogenesis and oxidative phosphorylation are reported to
be upregulated in metastatic cancer cells. Therefore, understanding the differential roles of mitochondrial
metabolic pathways and enzymes in disseminated cancer cells is crucial for determining factors that give cancer
cells a metastatic advantage. In order to colonize distant organs, cancer cells must first resist anoikis: an
apoptotic cell death mechanism triggered by loss of proper contact with the extracellular matrix. Our lab has
previously demonstrated that the mitochondrial enzyme glutamate dehydrogenase 1 (GDH1) contributes to
anoikis resistance and metastasis by regulating the bioenergetic response through reactivation of AMPK in
LKB1-deficient lung cancer. However, the role of other mitochondrial enzymes in anoikis resistance remains
poorly understood. To identify other factors important for cancer cell anoikis resistance, we performed an
unbiased RNAi screen targeting 120 mitochondrial enzymes in lung cancer cells and identified the ATP-specific
Succinyl-CoA Synthetase beta subunit (SUCLA2) as a factor that may be important for cancer cell survival after
ECM detachment. Stable knockdown of SUCLA2 sensitized multiple cancer cell lines to anoikis when cultured
under non-adherent conditions in vitro. Bioinformatic analysis of publicly available data indicates that higher
tumor SUCLA2 mRNA expression is associated with poor patient survival, and our immunohistochemistry
staining suggests that SUCLA2 protein levels are higher in metastatic lung cancer compared to matched primary
tumors. Additionally, our preliminary data suggests that SUCLA2 knockdown significantly increases oxygen
consumption rates (OCR) and reactive oxygen species (ROS) levels in ECM detached cancer cells. In this
proposal, we will employ multiple approaches to test our hypothesis that SUCLA2 promotes anoikis resistance
and tumor metastasis by modulating cellular redox status following ECM detachment. The specific aims of the
proposed research are 1) To determine whether SUCLA2 promotes anoikis resistance and metastasis of cancer
cells in an enzyme-dependent manner and 2) To decipher the molecular mechanism by which SUCLA2
contributes to cellular metabolism to promote cancer cell anoikis resistance. In the long term, we seek to
comprehensively characterize the metabolic pathways underlying SUCLA2's role in cancer cell anoikis
resistance, which will be critical to providing a greater understanding of the metabolic signaling mechanisms
underlying metastatic progression.
项目总结
转移性癌症很难治疗,而且往往是无法治愈的。前转移细胞通路的特征是
因此对于发现新的治疗靶点和转移的生物标志物以改善临床至关重要
癌症患者的预后。细胞代谢失调是癌症的一个公认的标志,但
越来越多的研究强调了原发和转移癌细胞之间的代谢差异。而当
高度增殖的原发肿瘤细胞通常表现出沃伯格效应,其特征是偏爱有氧
糖酵解产生ATP,线粒体生物发生和氧化磷酸化的基因被报道
在转移性癌细胞中上调。因此,理解线粒体的不同作用
播散性癌细胞中的代谢途径和酶是决定致癌因素的关键
细胞是转移的优势.为了在远处的器官中定居,癌细胞必须首先抵抗失巢凋亡:
由于失去与细胞外基质的适当接触而触发的细胞死亡机制。我们的实验室有
先前证明,线粒体酶谷氨酸脱氢酶1(GDH1)有助于
通过激活AMPK调节细胞的生物能量反应与肿瘤细胞的失巢抵抗和转移
LKB1基因缺陷的肺癌。然而,其他线粒体酶在失巢失巢抵抗中的作用仍然存在。
人们对此知之甚少。为了确定癌细胞失巢抵抗的其他重要因素,我们进行了一项
针对肺癌细胞中120个线粒体酶的无偏向RNAi筛选及鉴定
琥珀酰辅酶A合成酶β亚基(SUCLA2)可能是影响肿瘤细胞存活的重要因素
ECM支队。SUCLA2致敏的多种癌细胞在培养时对失巢凋亡的稳定敲除
在体外非贴壁条件下。公开数据的生物信息学分析表明,更高的
肿瘤SUCLA2 mRNA的表达与患者的生存不良有关,我们的免疫组织化学
染色显示转移性肺癌的SUCLA2蛋白水平高于匹配的原发肺癌
肿瘤。此外,我们的初步数据表明,SUCLA2基因敲除后显著增加了氧气
ECM分离癌细胞的消耗速率(OCR)和活性氧(ROS)水平。在这
提案中,我们将使用多种方法来验证我们的假设,即SUCLA2促进失巢抵抗
ECM脱离后,通过调节细胞氧化还原状态,促进肿瘤转移。《公约》的具体目标
建议的研究是:1)确定SUCLA2是否促进肿瘤的失巢凋亡抵抗和转移
2)破译SUCLA2的分子机制
有助于细胞代谢,促进癌细胞对失巢凋亡的抵抗。从长远来看,我们致力于
SUCLA2‘S在癌细胞失巢凋亡中作用的代谢途径研究
抗性,这将是提供更多的代谢信号机制的关键
潜在的转移进展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Austin C Boese其他文献
Austin C Boese的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Austin C Boese', 18)}}的其他基金
Metabolic reprogramming and tumor progression in LKB1 deficient NSCLC
LKB1 缺陷型 NSCLC 的代谢重编程和肿瘤进展
- 批准号:
10477469 - 财政年份:2021
- 资助金额:
$ 1.2万 - 项目类别:
Metabolic reprogramming and tumor progression in LKB1 deficient NSCLC
LKB1 缺陷型 NSCLC 的代谢重编程和肿瘤进展
- 批准号:
10305441 - 财政年份:2021
- 资助金额:
$ 1.2万 - 项目类别:
相似国自然基金
胃肠安方抑制整合素αvβ6促进胃癌细胞Anoikis防治胃癌转移的机制研究
- 批准号:82305335
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
AMPK通路调控CEMIP诱导自噬对前列腺癌细胞anoikis耐受的影响及机制
- 批准号:81772751
- 批准年份:2017
- 资助金额:55.0 万元
- 项目类别:面上项目
Myxoma 病毒蛋白Serp-1促进肝癌细胞Anoikis的作用及机制研究
- 批准号:81372597
- 批准年份:2013
- 资助金额:16.0 万元
- 项目类别:面上项目
TrkB/BDNF通路对前列腺癌EMT、anoikis和血管生成的影响及分子机制
- 批准号:81272847
- 批准年份:2012
- 资助金额:60.0 万元
- 项目类别:面上项目
E-cadherin调控卵巢癌细胞anoikis-resistance的分子机制及干预
- 批准号:81172487
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
NDRG1在肝癌细胞抵抗Anoikis中的作用及其机制研究
- 批准号:30873025
- 批准年份:2008
- 资助金额:30.0 万元
- 项目类别:面上项目
肝癌细胞抵抗anoikis关键分子的筛选和鉴定
- 批准号:30700357
- 批准年份:2007
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
阻遏供体鼠胰岛整合素介导的Anoikis延长移植胰岛存活率
- 批准号:30070724
- 批准年份:2000
- 资助金额:15.0 万元
- 项目类别:面上项目
相似海外基金
Role of lncRNA UCA1 in anoikis resistantce and colorectal cancer metastasis
lncRNA UCA1在失巢凋亡抵抗和结直肠癌转移中的作用
- 批准号:
10689777 - 财政年份:2022
- 资助金额:
$ 1.2万 - 项目类别:
A Novel Anoikis Effector that Drives Ovarian Cancer Metastasis
一种驱动卵巢癌转移的新型失巢效应器
- 批准号:
10117214 - 财政年份:2020
- 资助金额:
$ 1.2万 - 项目类别:
The novel anti-cancer activities of food components: the analysis about their inhibitory functions on the invasion, growth and metastasis of cancer cells via anoikis induction
食品成分的新型抗癌活性:分析其通过失巢凋亡诱导抑制癌细胞侵袭、生长和转移的功能
- 批准号:
19K05932 - 财政年份:2019
- 资助金额:
$ 1.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The new strategy for improving of cancer prognosis - The investigation of the mechanism of food components inducing anoikis in floating cells-
改善癌症预后的新策略 - 食品成分诱导漂浮细胞失巢凋亡的机制研究 -
- 批准号:
18K05536 - 财政年份:2018
- 资助金额:
$ 1.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Selective roles of integrins in the regulation of epithelial cell anoikis
整合素在上皮细胞失巢调控中的选择性作用
- 批准号:
227935-2013 - 财政年份:2015
- 资助金额:
$ 1.2万 - 项目类别:
Discovery Grants Program - Individual
Selective roles of alpha2, alpha3 and alpha5 integrin subunits in the regulation of intestinal epithelial cell anoikis
α2、α3和α5整合素亚基在肠上皮细胞失巢凋亡调节中的选择性作用
- 批准号:
459608-2014 - 财政年份:2015
- 资助金额:
$ 1.2万 - 项目类别:
Postgraduate Scholarships - Doctoral
Selective roles of alpha2, alpha3 and alpha5 integrin subunits in the regulation of intestinal epithelial cell anoikis
α2、α3和α5整合素亚基在肠上皮细胞失巢凋亡调节中的选择性作用
- 批准号:
459608-2014 - 财政年份:2014
- 资助金额:
$ 1.2万 - 项目类别:
Postgraduate Scholarships - Doctoral
肺癌進展における細胞接着及びAnoikisに関わる新規遺伝子の解析
肺癌进展中与细胞粘附和失巢凋亡相关的新基因分析
- 批准号:
26430137 - 财政年份:2014
- 资助金额:
$ 1.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of driver genes in lung cancer through a semi-genome wide shRNA library screen based on anoikis resistance phenotype
基于失巢凋亡抗性表型的半基因组全shRNA文库筛选鉴定肺癌驱动基因
- 批准号:
26293197 - 财政年份:2014
- 资助金额:
$ 1.2万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Selective roles of integrins in the regulation of epithelial cell anoikis
整合素在上皮细胞失巢调控中的选择性作用
- 批准号:
227935-2013 - 财政年份:2014
- 资助金额:
$ 1.2万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




